Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1.ALPHA.-OHD3) and 1,24 dihydroxycholecalciferol (1,24(OH)2D3).
Open Access
- 1 January 1985
- journal article
- research article
- Published by Japan Endocrine Society in Endocrinologia Japonica
- Vol. 32 (2) , 305-315
- https://doi.org/10.1507/endocrj1954.32.305
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesThis publication has 13 references indexed in Scilit:
- 1-34 Human parathyroid hormone radioimmunoassay: Properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application.Endocrinologia Japonica, 1981
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- Treatment of Osteoporosis with 1‐Alpha‐Hydroxycholecalciferol and CalciumActa Medica Scandinavica, 1980
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- 1,25 (OH)2Vitamin D3in Osteoporosis - A Pilot StudyHormone and Metabolic Research, 1979
- Role of Calcium Regulationg Hormones in the Pathogenesis of Senile OsteoporosisEndocrinologia Japonica, 1979
- BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENTThe Lancet, 1978
- Short‐Term Effects of 1‐Alpha‐Hydroxy‐Vitamin D3 in Patients on Corticosteroid Treatment and in Patients with Senile OsteoporosisActa Medica Scandinavica, 1978
- The influence of age on the intestinal absorption of 47-Ca absorption in post-menopausal osteoporosis.Journal of Clinical Investigation, 1965
- ISOTOPIC TRACER STUDIES OF INTESTINAL CALCIUM ABSORPTION1965